SPARSENTAN In IgA Nephropathy: An Update On The Clinical Trials
1:01:45
Targeting Glomerular Injury with Sparsentan to Preserve Kidney Function in Patients with IgA
1:07:20
IgA Nephropathy Basics (including an update on new treatments).
1:01:14
Clinical Trials Overview: Phrases and Phases of a Clinical Trials
1:01:55
AORTIC NA Series Part 4 Northwestern University Feinberg School of Medicine 7 Jan 2025
58:31
C3G and Primary IC-MPGN: Complement System Driven Glomerulopathies
27:15
O Conceito Mais Mal Compreendido da Física
3:49:35
Antihypertensive Drugs | Pharmacology | Dr Najeeb💊
38:36